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Abstract 
 As the king of herb plants, ginseng has been used for nearly 5000 years in medicines in Asia and recently in the West. 
Ginsenosides, the main active constituents in Panax herbs, have prominent immunoregulatory effects. Although 
extensively studied in the roots, ginsenosides have not been studied with regard to their profiles and natural vari‑
ations in the leaf, stem, petiole, lateral root, and main roots during development or among species. In this study, 
a sensitive ultra‑performance liquid chromatography‑electrospray ionization–mass spectrometry method with a 
shorter chromatographic running time was developed and validated for simultaneous quantification of ten ginseno‑
sides. Comparing ginsenoside contents in various parts during different developmental stages revealed part‑specific 
accumulation of most ginsenosides. Further investigation indicated that Rg3 accumulated at significantly higher 
levels in the petiole of P. ginseng than in that of P. quinquefolius. The relative ratio of ginsenoside Rb2 to Rb1 appears to 
be a candidate metabolic marker for identifying the ginseng cultivar within a diverse collection of ginseng accessions. 
In addition, the PCA showed that aboveground parts differed significantly between species and can be considered 
as species‑specific markers rather than roots. This comprehensive survey, providing reliable, affordable and adequate 
scientific evidence, could be used to differentiate two species and discriminate ginseng cultivar ages.
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Background
Ginseng (Panax ginseng C. A. Meyer), a perennial plant 
of the Araliaceae family, is a key component of tradi-
tional Chinese medicines (TCMs). It was discovered 
over 5000 years ago in China and today is still one of the 
most widely used botanicals in China, Korea and western 
countries (Wang et al. 1999). The genus Panax includes 
3 species including Panax ginseng (Asian or Korean gin-
seng), Panax notoginseng (Chinese ginseng, also called 
Sanchi ginseng), and Panax quinquefolius (American 
ginseng) (Qi et  al. 2011). In addition, there is consider-
able commercial interest in ginseng for food and health 
products. Recently, the root and rhizome of ginseng has 
been approved as a new resource food by the Ministry 
of Health of the People’s Republic of China. The roots of 
P. ginseng have diverse pharmacological effects, such as 
controlling blood pressure and stimulating the immune 
system, increasing learning and cognitive performance 
and antiaging, antioxidative, and anticancer activities 
(Christensen 2009; Keum et al. 2000). In northern China, 
the two major species are Panax ginseng and Panax 
quinquefolius, based on their morphological character 
and pharmacological function (Chen et al. 2008).
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The primary biochemical and pharmacological activi-
ties of Panax plants have been attributed to ginsenosides 
(Leung and Wong 2010; Wang et al. 2010). Ginsenosides 
are triterpenoid saponins (or ginseng saponins) that are 
secondary metabolites almost exclusively produced in 
Panax species (Liang and Zhao 2008). Ginsenosides differ 
from each other in the number, linkage position and type 
of sugar moiety. To date, more than 150 naturally occur-
ring ginsenosides have been identified from Panax plants 
(Zhao et al. 2015) and classified according to the aglycones 
ginsenoside skeleton into two major types: dammaranes 
and oleananes (Attele et  al. 1999). The dammarane-type 
ginsenosides have three types of aglycone moieties: pro-
topanaxadiol (PPD), protopanaxatriol (PPT), and oco-
tillol. The PPD-group saponins, such as ginsenosides Rb1, 
Rb2, Rc and Rd are glycosides, and each contains an agly-
cone with a dammarane skeletion, with sugar moieties 
attached to the β-OH at C-3 and/or C-20 (Table 1) (Yang 
et al. 2012). Ginsenosides Re, Rf, Rg1 and Rh1 belong to 
the PPT-type saponins, which consist of sugar moieties 
attached to the α-OH at C-6 and/or β-OH at C-20 (Fuz-
zati 2004). These ginsenosides commonly occur in Panax 
plants and are used in a wide range of pharmacological 
treatments for cancer, inflammation, allergy and hyper-
tension etc., due to their have an immunomodulatory 
effect (Angelova et al. 2008; Song et al. 2012).
Structural characterization to identify ginsenosides in 
different Panax species has been highly developed using 
LC-MS/MS and nuclear magnetic resonance (NMR) (Li 
et  al. 2000; Shergis et  al. 2013; Xie et  al. 2008; Yu et  al. 
2014). While NMR metabolite profiling provides a valu-
able metabolite signature of a complex sample, LC-MS 
has higher sensitivity and resolution, resolving individual 
chemical components into separate peaks (Nordstrom 
et al. 2006). Among the various LC platforms, the soaring 
development of column particle materials has highlighted 
a new addition to chromatographic separation technology, 
ultra-performance liquid chromatographic (UPLC) sepa-
ration technology, which allows satisfactory separation, 
good resolution and sensitivity, and high-speed detection 
for complex biological samples such as herbal medicines 
(Xie et al. 2008). An HPLC-based metabolic profiling and 
quantitative method has been developed for quality con-
trol of leaves of different Panax plants (Yang et al. 2013). 
Furthermore, UPLC analysis showed that the main roots 
of Panax ginseng and P. quinquefolius differ significantly 
in their levels of six ginsenosides (Xie et al. 2008). Never-
theless, comprehensive profiling of part and developmen-
tally specific accumulation of ginsenosides in ginseng has 
received little attention. In addition, because the length of 
the detection time needed for these methods interferes 
with the active components of the sample, a method with 
a shorter detection time needs to be developed.
In the present study, an integrated approach combining 
a UPLC assay with electrospray ionization–mass spec-
trometry was developed to identify part-specific, devel-
opmentally controlled accumulation of ginsenosides and 
determine whether the two main species of ginseng in 
northern China differentially accumulate ginsenosides. 
Our data showed that the newly established method is 
accurate, rapid and discriminatory for identifying the 




All chemicals were of analytical grade. Acetonitrile 
and methanol (J & K Scientific, Beijing, China) were of 
Table 1 Chemical structure of different types of ginsenosides and their classification based on the glycosides attached
Glc β-d-glucopyranosyl, Ara(p) α-l-glucopyranosyl, Ara(f) α-l-arabinofuranosyl, Rha α-l-rhamnopyranosyl
Structure Ginsenoside R1 R2 R3 Formula
Ginsenoside Rb1 –Glc2_1Glc –Glc6_1Glc C54H92O23
Ginsenoside Rb2 –Glc2_1Glc –Glc6_1Ara(p) C53H90O22
Ginsenoside Rc –Glc2_1Glc –Glc6_1Ara(f ) C53H90O22
Ginsenoside Rd –Glc2_1Glc –Glc C48H82O18
Ginsenoside Rg3 –Glc2_1Glc –H C42H72O13
Ginsenoside Rh2 –Glc –H C36H62O8
Ginsenoside Rg1 –Glc2_1Rha –Glc C42H72O14
Ginsenoside Re –Glc2_1Glc –Glc C48H82O18
Ginsenoside Rf –Glc –Glc C42H72O14
Ginsenoside Rh1 –Glc –H C35H62O9
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UPLC-grade. Deionized water was purified with a Milli-
Q Academic ultra-pure water system (Millipore, Milford, 
MA, USA). Ginsenoside Rg1, Re, Rb1, Rb2, Rc, Rd, Rf, 
Rh1, Rh2 and Rg3 were purchased from Beijing Science 
and Technology (Beijing, China). The purities of these 
standards were higher than 98  % according to HPLC 
analysis. Standard stock solutions were prepared using 
methanol as a solvent and stored at −20  °C. Standard 
solutions of ginsenosides were prepared just before use 
by mixing individual stock solutions and diluting these 
mixtures with methanol.
Plant materials
The ginseng core species used in this study were from the 
Changbai Mountain field base located in northeastern 
China (42°01′–43°24′ N, 127°48′–129°11′ E). Roots, lat-
eral roots, petioles, stems, and leaves at different devel-
opmental stages were collected from 1-, 2-, 3-, 4-, 5-year 
Panax ginseng and 5-year Panax quinquefolius, result-
ing in 90 individual samples (Fig. 1). For each part, three 
samples were obtained for analysis by mixing six individ-
ual samples together. All the samples were harvested at 
9:00 and 11:00 on 15 August 2015. Each group of plant 
part was carefully washed, cut into small pieces, and 
stored at −70  °C until vacuum freeze-drying. Samples 
were taken from three plants per line and pooled for each 
biological replicate.
Sample preparation and extraction
Analysis of ginsenosides compounds in Panax ginseng 
and Panax quinquefolius were performed combined with 
previous methods (Liu et al. 2016; Yu et al. 2014). In order 
to improve the extraction efficiency for ginsenoside, this 
extraction method was optimized. 1.0 g of each part was 
weighed, extracted overnight in a Soxhlet extractor and 
at 4  °C with 60 mL precision water-saturated n-butanol. 
The next day, the extract solution was filtered with a 
0.2  μm syringe filter (Millipore Co., Bedford, MA), the 
filtrate was separated with a funnel and washed with 
20 mL 2 % w/v NaOH solution. The upper solutions were 
combined and evaporated to dryness, then diluted to the 
desired volume with methanol. Following centrifugation 
at 10,000×g for 15 min, the extracts were absorbed and 
filtered through a 0.45  μm syringe filter before UPLC 
analysis.
Chromatographic conditions
Samples were separated at 25  °C using an Ultra-Perfor-
mance LC (UPLC) system (Waters, Japan) with a LC-
20AD pump, a temperature controller, column oven, 
SIL-20A autosampler (Waters, Japan), and ACQUITY 
UPLC BEH C18 Column (1.7 µm, 2.1 mm × 50 mm) with 
an in-line filter. The mobile phase consisted of (A) water 
and (B) acetonitrile in the elution program optimized 
as follows: 30 % B (0–4.5 min), 30–60 % B (4.5–6 min), 
60–90 % B (6–6.5 min), 90 % B (6.5–7.5 min), 90–30 % 
B (7.5–8  min), 30  % B (8–10  min). The flow rate was 
0.25 mL/min, and the injection volume was 5 μL.
Mass spectrometry conditions
Tandem mass spectrometry was performed using an 
QTRAP 5500 Ion Trap Mass Spectrometer (AB SCIEX, 
USA) equipped with an electrospray ionization (ESI) 
source in the positive ion detection mode. MS source 
conditions were set as follows: ion spray voltage, 5500 V; 
turbo spray temperature, 500  °C; high purity nitrogen 
was used in all units; nebulizer gas, 25  psi; curtain gas, 
20  psi. In this study, the level of ginsenosides observed 
in positive ion mode was higher than that in negative ion 
mode, so the positive ion mode was selected. Samples 
were quantified from positive multiple reactions, moni-
toring the m/z for Rg1, Re, Rd, Rb1, Rb2, Rf, Rh1, Rh2, 
Rg3, and Rc that gave 824.0, 970.0, 964.1, 1131.1, 1101.8, 
801.7, 639.2, 623.2, 786.1, and 1101.2, respectively. Dur-
ing infusion of each of the standards, the collision energy 
was varied from 12 to 83 V to find the optimal collision 
energy. The most abundant fragment ions for each gin-
senoside were chosen for the multiple reaction monitor-
ing. The optimal conditions for the mass spectrometry, 
for fragment ions and the main fragment ions of each 
ginsenoside gave 824.0 → 643.9 for Rg1, 970.0 → 789.9 
for Re, 964.1  →  767.2 for Rd, 1131.1  →  789.2 for 
Rb1, 1101.8  →  335.0 for Rb2, 801.7  →  424.2 for 
Rf, 639.2  →  621.1 for Rh1, 623.2  →  605.2 for Rh2, 
786.1 → 325.0 for Rg3, and 1101.2 → 334.4 for Rc. The 
declustering potential and collision energy were 70/61 for 
Rg1, 125/67 for Re, 111/17 for Rd, 120/83 for Rb1, 90/81 
for Rb2, 40/26 for Rf, 50/12 for Rh1, 160/13 for Rh2, 
60/15 for Rg3 and 149/76 for Rc. Data were collected 
using Analyst 1.4.2 software (AB SCIEX, Canada).
Statistical analyses
Ten ginsenosides were used in a hierarchical clustering 
analysis in the program R (www.r-project.org/) to study 
ginsenoside part-specific accumulation. Results were 
subjected to an analysis of variance (ANOVA) to deter-
mine any significant differences between differential spe-
cies. If the ANOVA showed any significant differences, 
then Duncan’s honestly significant difference (HSD) post 
hoc test was used to determine any differences between 
individual treatments (SPSS 17.0, SPSS, USA). Principal 
component analysis was used to compare the develop-
ment stage and different species according to the ginse-
noside profiles of different parts.
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Results
Establishment of UPLC/MS method for ginsenoside 
analysis
Owing to the complexity of metabolites, many com-
ponents may be coeluted during analyses. To develop a 
sensitive and accurate UPLC/MS method for determin-
ing the active compounds in ginseng, we used a triple 
quadruple mass spectrometer equipped with ESI, one of 
the most useful tools available for simultaneous quantifi-
cation of ginsenosides, to analyze the compounds in gin-
seng. To quantify the analytes using the MRM mode, we 
evaluated full scan and product ion spectra of the ana-
lytes. First, in tests of positive and negative ion detection 
modes, the positive ESI achieved higher sensitivities than 
the negative. With positive ESI, Rd, Rf, Rh1, Rh2, and Rg3 
formed predominately protonated molecules, [M + H]+, 
at m/z 964.1, 801.7, 639.2, 623.2, and 786.1, respectively, 
in the full-scan spectra. In addition, Rg1, Re, Rb1, Rb2, 
and Rc predominantly formed sodium adduct ions, 
[M  +  Na]+, at m/z of 824.0, 970.0, 1131.1, 1101.8, and 
1101.2 with the response approximately 5 times higher 
than with [M + H]+. The [M + H]+ and [M + Na]+ ions 
were therefore chosen as the precursor ions to obtain 
their major fragment ions for MRM analysis. The frag-
ment ions at m/z values of 643.9, 789.9, 767.2, 334.4, 
621.1, 605.2, 789.2, 335.0, 325.0, and 424.2, were present 
in the highest abundance for Rg1, Re, Rd, Rc, Rh1, Rh2, 
Rb1, Rb2, Rg3, Rf, respectively (Additional file 1: Figure 
Fig. 1 Schematic illustrations of collected parts of Panax ginseng and P. quinquefolius. a–e. P. ginseng: a 1, b 2, c 3, d, 4, e 5 years old. f P. quinquefo-
lius: 5 years old
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S1). The instrument was tuned to yield the maximum 
product ion for each compound.
In optimizing the UPLC system to detect the 10 ginse-
nosides, chromatographic separation was tested on sev-
eral C18 columns to achieve the best efficiency and peak 
shape. The ACQUITY UPLC BEH C18 column (1.7  μm, 
2.1 mm × 50 mm) gave good peak shape when ultra-pure 
was used as the mobile phase. Different mobile phases 
were evaluated to improve LC separation and enhance 
MS sensitivity. When methanol and acetonitrile were 
tested as the organic modifier, acetonitrile was superior 
for ionizing most ginsenosides. In tests on the isocratic 
and gradient systems, the gradient system achieved bet-
ter peak shape than the isocratic system; thus, a gradient 
elution with a mobile phase consisting of acetonitrile and 
no acid in water gave optimal peak shape and mass spec-
tral response for the analytes.
The representative total ion current (TIC) spectra in 
10 min was obtained from the analysis (Fig. 2). The reten-
tion time of Re, Rg1, Rf, Rb1, Rh1, Rc, Rb2, Rd, Rg3, and 
Rh2 was 0.76, 0.78, 2.32, 2.97, 3.48, 3.69, 4.94, 5.83, 6.69, 
and 7.34  min, respectively. No endogenous interference 
was detected at these retention times for the 10 analytes; 
therefore, high, very acceptable selectivity was achieved 
by this method. Regression equations and a linear range 
for calibration curves were also obtained. To avoid bias to 
the low concentrations of the standard curve caused by 
the high concentrations, the calibration curves were sep-
arated for different ranges. Within the linear range, the 
calibration curve had good linearity (r2 > 0.999) for each 
analyte (Additional file 2: Table S1). In addition, the pro-
posed method delivers reliable accuracy and good repro-
ducibility for the simultaneous separation and detection 
of the metabolites using UPLC/MS (Additional file  2: 
Table S2, 3). The optimized method was employed for the 
determination of the ginsenosides by comparing the area 
calculated for each peak to the standard curves obtained 
from the authentic ginsenoside standards (Additional 
file  2: Table S1). Calibration curves were plotted using 
five concentrations of each ginsenoside standard accord-
ing to the peak area.
Specific accumulation of ginsenosides in various parts of P. 
ginseng
To investigate the accumulation of ginsenosides in dif-
ferent part of P. ginseng, samples from five different parts 
were collected, including leaf, petiole, stem, lateral root, 
and main root. For each part, samples from different 
Fig. 2 UPLC chromatographic fingerprints of 10 standard solutions at 1 min Rg1 (10 min separation on a 1.7 µm, 2.1 mm × 50 mm ACQUITY UPLC 
BEH C18 column)
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growth stage were obtained. The profile for the main 
ginsenosides was visualized using a hierarchical cluster 
analysis (HCA; Fig.  3). Accumulation of the ginseno-
sides displayed a clear phenotypic variation in terms of 
their abundance in different parts of the same age. Roots 
contained the highest levels of most ginsenosides, fol-
lowed by lateral roots, stems, and petioles; leaves had 
the lowest. In addition to the greatest accumulation of 
ginsenosides, roots also had the most complex profile 
for ginsenoside composition in the different ages of the 
parts.
Based on their part- and growth stage-specific accu-
mulation patterns, ginsenosides could be clearly grouped 
into five stages (Fig.  3a). Ginsenosides in the first year 
had higher levels in lateral roots than in other parts and 
were mainly represented by PPD-type ginsenosides, 
including some of the major ginsenosides such as Rc, 
Rb1, and Rd. In the second year, the PPD-type such as 
Rc, Rb2, Rg3, and Rd predominated, again with higher 
levels in lateral roots. Moreover, in the same stage, other 
ginsenosides had their highest levels in the main roots 
and were mainly represented by PPT-type, Re, Rg1, and 
Rf. Major PPD- (Rc, Rb2, Rd, and Rg3) and PPT-types 
(Re and Rg1) were tightly grouped in lateral roots and 
main roots, respectively, during the third year. Three 
PPD-types, including Rc, Rh2 and Rg3, in the fourth year 
were significantly higher in lateral roots than in leaves, 
petioles, stems and main roots. Furthermore, one PPD-
(Rb1) and two PPT-types (Rg1 and Rf ) significantly 
accumulated in the main roots. Re and Rg1 during the 
fifth year had highest levels in the main roots and were 
mainly represented by PPT, which have been character-
ized for their medicinal value. However, the PPD-type 
Rh2 had higher levels in lateral roots, followed by stems, 
petioles, main roots and leaves. In addition, PPD-types 
Rb1, Rb2 and Rg3 showed the same accumulation pat-
tern as the PPT-types Re and Rg1, suggesting highest 
accumulation in the main roots than in other parts dur-
ing the fifth year.
In addition, the “Q” score of the principal component 
is an indicator of a comprehensive, scientific evaluation 
of objective phenomenon, which has no practical sig-
nificance. In the Fig. 3b, the comprehensive PCA Q value 
result revealed that the overall accumulation of ginseno-
sides in different parts and stages followed a relatively sta-
ble distribution. The above- and belowground parts could 
be clearly differentiated, except for the roots of 1-year 
olds. Leaves contained the lowest levels of ginsenosides, 
followed by petioles and stems, and second year and fifth 
year parts shared this uniform tendency, which these gin-
senosides in leaves had lower levels than in the petioles 
and stems. Contrasting the aboveground parts ginseno-
sides changing, we observed that the belowground parts 
(lateral roots and main roots) increasing their concentra-
tion in main roots is higher than those increasing their 
concentration in lateral roots of 2- and 3-year-old plants. 
In addition, an increase of the number of Q value which 
accumulate higher in lateral roots than main roots during 
4 to 5-year-old samples.
Ginsenoside accumulation patterns during development
To further clarify ginsenoside accumulation patterns 
during different developmental stages, five parts were 
sampled at five stages, and the 10 major ginsenosides in 
each part were quantified. Ginsenosides with different 
modifications accumulated differently at different devel-
opmental stages. The various forms of ginsenosides were 
subsequently quantified, and the major ginsenosides were 
selected to determine the range of variations observed in 
leaves, petioles, stems, lateral root and main roots during 
each stage (Fig. 4).
Most PPD-types such Rb1, Rb2, Rc and Rg3 signifi-
cantly increased in the roots during years 1–5 (R1–R5) 
(Fig.  4a). The levels of Rb1 and Rb2, showed marked 
cross-change during the lateral root stage (LR2–LR5), 
sharply increasing at early stages (P1–P2). Levels of 
Rb2 decreased over time in stems (S1–S5). Rb1 and Rd 
sharply decreased and Rb2 and Rh2 levels increased in 
leaves during later stages (L2–L5). For most of the PPT-
types such as Rg1, Re and Rh, accumulation in roots sig-
nificantly increased during R1 to R5 (Fig.  4b). In lateral 
roots, Rg1 and Re sharply increased during LR1 to LR3. 
However, Rg1 sharply decreased during LR4 to LR5 and 
for Re during LR3–LR5. In addition, the level of Rg1 and 
Re had an inverse relationship during all petiole stages 
(P1–P5). Re and Rf increased in a similar way in stems 
(S1–S5). In contrast, a discrepant synthesis of Re and Rh1 
during leaf development (L1–L5) suggested that their 
accumulation was developmentally controlled.
Differential accumulation of ginsenosides between P. 
ginseng and P. quinquefolius
Differences in genetic background and geographical dis-
tribution between P. ginseng and P. quinquefolius may 
lead to differing accumulation and composition of gin-
senosides in these two species. For each part sample 
(leaf, petiole, stem, lateral root, main root), the relative 
concentration of each ginsenoside of interest was deter-
mined for P. ginseng and P. quinquefolius (Fig. 5).
In the main roots, the levels of seven ginsenosides 
differed significantly between the two species. Among 
them, four PPD-types (Rb1, Rb2, Rc, Rg3) were higher 
in P. ginseng than in P. quinquefolius. Three major PPT-
types (Rg1, Re, Rh1) were higher in P. ginseng than in P. 
quinquefolius (Fig.  5a), but Rg3, Rg1, and Rh2 in lateral 
roots were lower in P. ginseng than in P. quinquefolius 
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Fig. 3 Distribution of ginsenosides in leaf, stem, petiole, lateral root, and main root samples of P. ginseng at different growth stages. Heat map 
visualization of relative differences of ginsenosides in different growth stages of five parts. a Content of each ginsenoside, normalized for linkage 
hierarchical clustering. Each part type is visualized in a single column, and each ginsenoside is represented by a single row. Red indicates high relative 
abundance; green is low relative abundance (see color key above the heat map). b Score plot for principal component analysis. Negative values are 
below the average
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(Fig.  5b). In stems, major PPD-types Rb1, Rb2, Rd, and 
Rg3 were significantly elevated levels in P. quinquefolius 
compared with P. ginseng (Fig.  5c). In petioles, Rg3 was 
80 times higher and Rh1 was 3 times higher in P. ginseng 
than in P. quinquefolius (Fig.  5d). Similarly, Rb2, Rc, Rf, 
and Rh2 levels in leaves were higher in P. ginseng than 
in P. quinquefolius, whereas Rb1, Rg3, Rg1 and Re were 
significantly higher in P. quinquefolius than in P. ginseng 
(Fig. 5e). No significant difference was found between the 
two species for Rd and Rh1. Furthermore, a two-dimen-
sional PCA score plot (Fig.  5f ) was able to discriminate 
the differential levels in parts between P. ginseng and P. 
quinquefolius, thus simplifying data management. The 
above results suggested that the levels of ginsenosides 
in the two Panax species could be determined through 
UPLC coupled with PCA and the values of ginsenosides.
Discussion
As compared with simultaneous determination of several 
ginsenosides in P. ginseng, a metabolite profiling study 
requires higher resolution and sensitivity. The UPLC-
ESI–MS system used here provides a rapid, effective, and 
convenient profiling analytical method for a wide range 
of ginsenosides present in P. ginseng. Compared with pre-
vious HPLC and UPLC research hampered by run times 
as long as 70 and 21 min (Li et al. 2005; Wu et al. 2015; 
Yang et al. 2013), the major ginsenosides were excellently 
separated with superior peak shapes, especially the 10 
saponins quantified and qualitated during a 10-min run. 
In this method, ginsenosides with various modifications 
were in this study. Coinciding with previous reports 
on roots of P. ginseng and P. quinquefolius, PPD and 
PPT-type ginsenosides were found. Besides, the method 
can be used to differentiate P. ginseng and P. quinquefo-
lius, especially to distinguish their cultivation stage and 
species. In addition, ginsenosides are used in biologi-
cal/pharmacological experiments, thus the understand-
ing of the levels in different parts and different genus is 
of largely importance. Often there is inconsistency in 
biological activities of ginsenosides, such as anti-cancer 
(Rg1, Rg3 and Rb1), mmunomodulatory (Re), neuropro-
tective (Rf ), radioprotective (Rh1), hypoglycemic activi-
ties (Rb2) and anti-stress properties (Rc and Rd) (Cho 
2012; Joo et  al. 2010; Shibata 2001; Zhao et  al. 2011). 
Therefore, a comprehensive analysis of specific parts and 
developmental stages and to identify the species and age 
are essential for ginseng.
The levels of various ginsenosides in the roots of the 
Panax species could be used to identify the stage of 
development (Dan et al. 2009; Mao et al. 2014). A rapid 
examination of the qualitative and quantitative dif-
ferences in the ginsenosides present in various parts 
of ginseng at different developmental stages allowed 
a comprehensive profiling and a better understand-
ing of the distribution of the active ingredients within 
the plants. In addition to having the highest amount of 
ginsenosides, the roots also yielded the most complex 
profile of ginsenosides in the different parts, suggest-
ing potential diversity in the pharmacological compo-
nents in other parts of the plants, such as saponins in 
the leaves. Ginsenosides not only increase immune sys-
tem, adjust the body’s function, and promote metabo-
lism, and affects a wide range of biological activities 
in the nervous system, cardiovascular system, and 
Fig. 4 Accumulation patterns of different ginsenosides in main roots, lateral roots, petioles, stems, and leaves at various developmental stages of 
Panax ginseng. a Protopanaxadiol‑type ginsenosides. b Protopanaxatriol‑type ginsenosides. FW fresh mass. The full name of parts abbreviations R1, 
2, 3, 4, 5 are main roots 1 year old, 2 years old, 3 years old, 4 years old, 5 years old; LR1, 2, 3, 4, 5: lateral roots 1, 2, 3, 4, 5 years old; P1, 2, 3, 4, 5: petioles 
1, 2, 3, 4, 5 years old; S1, 2, 3, 4, 5: stems 1, 2, 3, 4, 5 years old; L1, 2, 3, 4, 5: leaves 1, 2, 3, 4, 5 years old. Each bar represents the mean ± SEM, n = 3
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immune system, but also have been widely used in clini-
cal practice (Shan et  al. 2014). Previous investigations 
on leaves of P. ginseng identified 37 compounds using 
UHPLC-QTOF-MS/MS (Mao et al. 2014) and suggested 
that ginsenosides provide the main medical activ-
ity in ginseng leaves. While quantitatively analyzing 
Fig. 5 Differential accumulation of ginsenosides in main roots, lateral roots, petioles, stems, and leaves between Panax ginseng and P. quinquefolius. 
a Main roots. b Lateral roots. c Stems. d Petioles. e Leaf. FW, fresh mass. f Two‑dimensional diagrams of PCA1 and PCA2. For Panax ginseng: red main 
root, blue lateral root, purple stem, light blue petiole, yellow leaf. For P. quinquefolius: green main root, dark yellow lateral root, dark green stem, dark red 
petiole, black leaf. Mean values with the same letter within a column did not differ significantly according to Duncan’s multiple comparison test with 
a family error rate of 0.05. Each bar represents the mean ± SEM, n = 3
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ginsenosides in leaves, we found that Rb2 and Rh2 accu-
mulate during leaf growth, suggesting possible roles of 
Rb2 and Rh2 in ginseng leaf growth and medical effi-
cacy, since Rh2 is a key component in the inhibition of 
cancerous cells (Liu et al. 2015b). In developing ginseng 
roots, some ginsenosides steadily accumulate peaking 
in older roots (Liu et al. 2015a). In addition, our study 
showed that all types of ginsenoside were higher in the 
roots than in other parts, thus explaining why the roots 
are the major source of drugs. Thus, based on our evalu-
ation of the profiles of different ginsenosides, the accu-
mulation of ginsenosides in ginseng is part-specific and 
developmentally dependent, further suggesting their 
widespread spatial distribution in the plants and a spe-
cial use for determining the age of the parts.
In addition, some ginsenosides differentially accumu-
lated between P. ginseng and P. quinquefolius, suggesting 
that the ratio of Rb2 to Rb1 could be used as a biomarker 
to discriminate P. ginseng from P. quinquefolius. A ratio 
less than 0.4 for Rb2/Rb1 in roots is indicative of P. 
quinquefolius; a significantly higher value indicates P. 
ginseng (Yuan et al. 2010). In the present study, the Rb2/
Rb1 ratio in P. quinquefolius was 0.05 and 1.1 in P. gin-
seng leaves. However, the ratio of Rb2/Rb1 followed an 
opposite trend in stems with a ratio of 1.2 in P. ginseng 
and 0.1 in P. quinquefolius. Another significant factor was 
the level of the ginsenoside Rg3 in P. ginseng, which was 
nearly 80 times higher than in the petiole of P. quinque-
folius (Fig. 5d). These results suggested that the Rb2/Rb1 
ratio in roots, leaves, and stems and the Rg3 content are 
good candidate metabolic markers for identifying the 
ginseng species within a diverse collection of ginseng 
accessions. In addition, the stems, leaves, and petioles of 
plants can be sampled to make a cleared significant dis-
tinction (Fig. 5f ), so the valuable roots do not need to be 
sacrificed. The differential accumulation of ginsenosides 
between P. ginseng and P. quinquefolius further establish 
the basis for the differences in the medical efficacy of the 
two species.
Conclusions
The highly sensitive UPLC–MS method was developed 
in the present study to simultaneously determine the 10 
ginsenosides (Rg1, Re, Rb1, Rb2, Rc, Rd, Rf, Rh1, Rh2 and 
Rg3) in two ginseng species compromising the merits 
of selectivity, detection speed, precision, accuracy, and 
extraction recovery. The analysis of different parts at dif-
ferent developmental stages is thus fast and easy due to 
the relatively short chromatographic running time. This 
study is the first comprehensive analysis of ginseno-
sides with main concern on part type and developmen-
tal stage in the two major species of Panax, P. ginseng 
and P. quinquefolius. Rg3 accumulated at significantly 
higher levels in the petiole of P. ginseng than in that of 
P. quinquefolius. The relative ratio of ginsenoside Rb2 
to Rb1 appears to be a candidate metabolic marker for 
identifying the ginseng cultivar within a diverse collec-
tion of ginseng accessions. On the other hand, through 
aboveground parts to discriminate age and species, we 
can preserve the great medicinal value roots. Hence, this 
work is of great importance for authenticate commercial 
ginseng samples regardless of the species, plant parts 
and ages, ultimately this strategy is promising for reveal-
ing and elucidating the metabolic outcomes as a result of 
plant origin, parts, growth stage and different cultivation 
methods.
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